1. Home
  2. CACI vs ROIV Comparison

CACI vs ROIV Comparison

Compare CACI & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CACI International Inc.

CACI

CACI International Inc.

HOLD

Current Price

$558.51

Market Cap

12.9B

Sector

Technology

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$22.56

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACI
ROIV
Founded
1962
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
14.1B
IPO Year
1979
N/A

Fundamental Metrics

Financial Performance
Metric
CACI
ROIV
Price
$558.51
$22.56
Analyst Decision
Buy
Strong Buy
Analyst Count
14
8
Target Price
$616.50
$24.31
AVG Volume (30 Days)
263.0K
8.2M
Earning Date
01-21-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
12.06
N/A
EPS
22.62
N/A
Revenue
$8,858,558,000.00
$20,329,000.00
Revenue This Year
$10.71
N/A
Revenue Next Year
$6.15
$376.94
P/E Ratio
$24.60
N/A
Revenue Growth
12.61
N/A
52 Week Low
$318.60
$8.73
52 Week High
$632.77
$23.47

Technical Indicators

Market Signals
Indicator
CACI
ROIV
Relative Strength Index (RSI) 37.73 61.61
Support Level $548.10 $21.60
Resistance Level $566.00 $23.47
Average True Range (ATR) 17.35 0.88
MACD -6.94 0.06
Stochastic Oscillator 10.64 69.09

Price Performance

Historical Comparison
CACI
ROIV

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: